AJR Am J Roentgenol
- CALLIADA F
Editorial Comment: Multiparametric Ultrasound Assessment of Hepatic Fat Fraction
in a Real-World Population.
AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.31226.
Am J Gastroenterol
- PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
High incidence rate of CT-measured steatotic liver disease in men with and
without HIV infection.
Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
- SILKE L, Donata G, Dominik G, Uli F, et al
Endoscopic features of post-COVID-19 cholangiopathy and its management using
ERCP.
Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
- KHANNA S, Shah NL, Argo CK
Use of Phosphatidylethanol Testing in Patients With Liver Disease.
Am J Gastroenterol. 2024;119:596-599.
- PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
Practical Considerations to Optimize Care for Patients With Alcohol-Associated
Liver Disease in General Gastroenterology Practice.
Am J Gastroenterol. 2024;119:591-595.
Biochem Biophys Res Commun
- ZHENG E, Chen Q, Xiao A, Luo X, et al
Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2
signaling pathway.
Biochem Biophys Res Commun. 2024;707:149781.
BMC Gastroenterol
- TADOKORO T, Nomura T, Fujita K, Manabe T, et al
Management of hepatocellular carcinoma, an important cause of death in Japanese
autoimmune hepatitis patients.
BMC Gastroenterol. 2024;24:123.
Dig Dis Sci
- PEARLMAN BL
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection
and Decompensated Cirrhosis.
Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
- WANG H, Liu X, Xie Y, Qin X, et al
A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
Hepatology
-
Erratum: AASLD Practice Guidance on Acute-on-chronic liver failure and the
management of critically ill patients with cirrhosis.
Hepatology. 2024 Mar 29. doi: 10.1097/HEP.0000000000000857.
- TAPPER EB, Warner MA, Shah RP, Emamaullee J, et al
Management of coagulopathy among patients with cirrhosis undergoing upper
endoscopy and paracentesis: Persistent gaps and areas of consensus in a
multispecialty Delphi.
Hepatology. 2024 Apr 1. doi: 10.1097/HEP.0000000000000856.
- TAFALENG EN, Li J, Wang Y, Hidvegi T, et al
Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the
hepatic phenotype in alpha1-antitrypsin deficiency.
Hepatology. 2024 Apr 1. doi: 10.1097/HEP.0000000000000865.
- SUN C, Zhou C, Daneshvar K, Ben Saad A, et al
Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction
with PML in hepatic stellate cells.
Hepatology. 2024 Apr 2. doi: 10.1097/HEP.0000000000000822.
-
Hepatology Highlights.
Hepatology. 2024;79:525-526.
Int J Cancer
- KARA-ALI GH, Cano L, Dion S, Imerzoukene G, et al
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is
associated with immune checkpoint upregulation.
Int J Cancer. 2024;154:1999-2013.
J Gastroenterol Hepatol
- CHAN WK, George J
Metabolic fatty liver syndromes: where do we stand in 2024?
J Gastroenterol Hepatol. 2024;39:613-614.
- PARENTE A, Milana F, Hajibandeh S, Hajibandeh S, et al
Clinical outcomes after transplantation of domino grafts or standard deceased
donor livers: a systematic review and meta-analysis.
J Gastroenterol Hepatol. 2024;39:620-629.
- SOGABE M, Okahisa T, Kagawa M, Sei M, et al
Association of metabolic dysfunction-associated fatty liver disease with
gallstone development: A longitudinal study.
J Gastroenterol Hepatol. 2024 Jan 11. doi: 10.1111/jgh.16483.
J Hepatol
- CHAN SL, Ryoo BY, Mo F, Chan LL, et al
Multicentre phase II trial of cabozantinib in patients with hepatocellular
carcinoma after immune checkpoint inhibitor treatment.
J Hepatol. 2024 Mar 26:S0168-8278(24)00216-2. doi: 10.1016/j.jhep.2024.
- HEUSCHKEL MJ, Bach C, Meiss-Heydmann L, Gerges E, et al
Erratum to 'JAK1 promotes HDV replication and is a potential target for antiviral
therapy' [J Hepatol 80 (2024) 220-231].
J Hepatol. 2024 Mar 30:S0168-8278(24)00165-X. doi: 10.1016/j.jhep.2024.
PLoS One
- BAGER P, Bossen L, Gantzel R, Gronbaek H, et al
High-dose oral thiamine versus placebo for chronic fatigue in patients with
primary biliary cholangitis: A crossover randomized clinical trial.
PLoS One. 2024;19:e0301354.
- CAI W, Qiu T, Hu W, Fang T, et al
Changes in the intestinal microbiota of individuals with non-alcoholic fatty
liver disease based on sequencing: An updated systematic review and
meta-analysis.
PLoS One. 2024;19:e0299946.
- CHEN R, An Y, Xu M
Prognostic difference between surgery and external radiation in patients with
stage I liver cancer based on competitive risk model and conditional survival
rate.
PLoS One. 2024;19:e0298014.
- AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
Impact of COVID-19 vaccination on liver transplant recipients. Experience in a
reference center in Mexico.
PLoS One. 2024;19:e0301198.
- RAN S, Song L, Yang H, Yu J, et al
Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-kappaB-mediated
hepatocyte pyroptosis.
PLoS One. 2024;19:e0301133.
- WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
OXIDATIVE study: A pilot prospective observational cohort study protocol
examining the influence of peri-reperfusion hyperoxemia and immune dysregulation
on early allograft dysfunction after orthotopic liver transplantation.
PLoS One. 2024;19:e0301281.
Radiology
- YOON JH, Kim YK, Kim JW, Chang W, et al
Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using
Gadoxetic Acid-enhanced Liver MRI.
Radiology. 2024;311:e233114.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016